Just last year, the United States Food and Drug Administration announced a ruling establishing stricter regulations for dietary supplements. The new regulations scheduled to be phased in over the next several years are intended to ensure that all dietary supplements are produced in a quality manner, do not contain contaminants or impurities and are accurately labeled by 2010. The tighter regulation could drive many smaller supplement marketers out of business.
And although the supplement industry is often criticized for its lack of research and regulation, roughly one in seven adults in the United States use dietary supplements to help expedite weight loss, according to the Journal of the American Dietetic Association.
DEX-C20 Caralluma is a new diet supplement currently undergoing a 100-person, randomized, double-blind placebo-controlled study. The multi-center study is taking place in three research facilities across three states.
"In the initial 10-person efficacy study we performed with DEX-C20, 10 out of the 10 patients lost weight," says Dr. Richard M. Goldfarb, medical director at Bucks County Clinical Research, an FDA-approved clinical research facility. "Participants showed a weight loss of 10-12 pounds in 30 days when using DEX-C20 in conjunction with diet and exercise and 5-7 pounds when using DEX-C20 alone without making lifestyle changes."
A key ingredient in DEX-C20 Caralluma comes from a succulent in India, called caralluma fimbriata, which is a cactus-like plant. While caralluma is not widely known in the United States, a specific form of it called Slimaluma (used in DEX-C20) has been rigorously tested in a total of 13 safety studies and double-blind human studies. In those studies, Slimaluma has illustrated benefits including appetite suppression and reduction in waist circumference without adverse side effects.
For more information about Dex-C20 Caralluma, visit www.dexC20.com.